| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today that Stephen E. Croskrey has informed the Board of Directors that he will retire as Chief Executive Officer not later than the end of this calendar year.
In connection with his retirement announcement, Mr. Croskrey has resigned from his position as Chairman of the Board, effective May 20, 2024, though he will continue to serve on the Board through his current term and will be a nominee for reelection at this year's annual meeting of stockholders. The Board has appointed Richard J. Hendrix as Chairman, serving in that role upon Mr. Croskrey's resignation as Chairman. Mr. Hendrix also will serve as Interim Executive Chairman during the period of transition to identify a CEO to succeed Mr. Croskrey. Additionally, the Board has formed an Executive Committee comprised of Mr. Hendrix, John Amboian, David Moody, and Mr. Croskrey. The Executive Committee will be charged with leading the search process for a new CEO, along with oversight of strategy and shareholder engagement during the transition period. More detail regarding Mr. Croskrey's retirement can be found in the 8-K filed by the Company today.
Posted In: DNMR
